Many individuals begin and cease GLP-1s. Right here’s why which may be a foul concept : NPR

[ad_1] <img src="https://npr.brightspotcdn.com/dims3/default/strip/false/crop/2836x1890+0+0/resize/1100/quality/50/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F42%2Ffe%2F1cd2e64f4e69a24a983c95a408d9%2Fap25128651411178.jpg" data-template="https://npr.brightspotcdn.com/dims3/default/strip/false/crop/2836x1890+0+0/resize/{width}/quality/{quality}/format/{format}/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F42%2Ffe%2F1cd2e64f4e69a24a983c95a408d9%2Fap25128651411178.jpg" class="img" alt="Wegovy and Zepbound are arranged for a photograph in California on Thursday, May 8, 2025." fetchpriority="high"/> Wegovy and Zepbound are GLP-1 weight reduction therapies. They're out there by prescription. JoNel Aleccia/AP conceal caption

toggle caption

JoNel Aleccia/AP It is fairly widespread for folks to start out on GLP-1 medication like Ozempic and Zepbound, particularly because the diabetes and weight problems therapies turn out to be extra ubiquitous. They're designed to deal with persistent circumstances, so the medicines are supposed for lifelong use; but a excessive share of people that begin them additionally give up.

"We discovered that fewer than one in 4 sufferers remained on a GLP-1 remedy after a 12 months," says Dr. Jaime Almandoz, an weight problems drugs specialist on the College of Texas Southwestern Medical Heart. He checked out insurance coverage claims knowledge in a analysis letter printed in JAMA and located that few sufferers truly adhere to the medication for the long run.

"Many occasions weight problems therapy is framed as a restricted period intervention that after folks get to a weight purpose or share of weight discount, that then therapy could be discontinued," Almandoz says. That is outdated considering, he argues. Sufferers additionally cease due to price, lack of insurance coverage, or unwanted effects.

Apparently, a separate survey discovered that most individuals who give up the medication mentioned they plan to restart, says Leigh O'Donnell, who analyzes shopper conduct for the market-research agency Kantar. "Seventy-four p.c of lapsers say that they're seemingly or very prone to come again onto a GLP-1," she says. And shopper conduct is shifting very quickly, as extra medication turn out to be out there in capsule kind, at a cheaper price, and from varied on-line sellers with out physician or insurance coverage approvals. "The boundaries to make use of and reuse are getting so low that it is a little bit exhausting to undertaking."

As with many issues regarding GLP-1s, shopper conduct is way outpacing analysis concerning the results of their use in several conditions. There is not quite a lot of analysis on the well being results of periodic use, although different research present weight regain after stopping GLP-1s is quicker in comparison with different diets that concentrate on conduct adjustments.

But, as O'Donnell notes, on-again-off-again use is already within the cultural zeitgeist. Celeb use of the drug as a type of food plan support is "normalizing" biking conduct, she says.

Social media advertisements capitalize on that message, too. One on-line vendor, Willow, options youthful, fit-looking girls in its advertisements, saying GLP-1s can be found even to individuals who put on a dimension 4. In a single such video, a svelte younger girl on a sofa asks a health care provider, "I am solely seeking to lose a few kilos, perhaps use it briefly." The physician assures her it is effective for temporary use.

Willow didn't reply to requests in search of remark about its advertising. Late final 12 months, Willow declined to switch or discontinue its health-related claims on the Higher Enterprise Bureau's request.

The pharmaceutical business, represented by the commerce group PhRMA, want to see Medicare guidelines modified to permit extra sufferers to take the medication and is pushing for extra oversight and reining in of a few of the compounding pharmacies that promote GLP-1 medication on to shoppers.

Specialists say one downside is that short-term use might undermine well being by diminishing lean muscle mass, each time an individual resumes GLP-1s.

As a lot as 40% of all weight misplaced on GLP-1s is lean muscle, says Mahmoud Salama Ahmed, a medical chemist at Texas Tech College. Whereas muscle loss is normal with any food plan or weight-loss routine, lack of muscle on GLP-1s could be extra dramatic, Ahmed says, inflicting what's been dubbed "Ozempic face," a bonier, looser-skinned look, the place the muscle loss is especially noticeable.

The issue, he says, is that when folks cease the medication, they have an inclination to realize again fats quickly. In the meantime, it isn't clear how – or how a lot – the muscle they misplaced can also be ultimately regained. If the affected person does not work to rebuild that lean mass, Ahmed says, that might result in sarcopenia – muscle loss – which adversely impacts stability, motion, metabolism and may result in damaged or weakened bones.

"We'd discover some actual issues if we're not monitoring the physique composition, particularly for the older sufferers," Ahmed says.

Nonetheless, some say the impacts on muscle won't be so dire; that GLP-1s additionally enhance muscle high quality, even when they scale back total amount.

When checked out intently, the muscle groups of these on GLP-1s seem like more healthy — with much less fats infiltration and higher, stronger fibers, says heart specialist Ian Neeland at Case Western Reserve College.

"The important thing level isn't just how a lot muscle, however how wholesome and practical the muscle is," Neeland says, as a result of the purpose is all the time to realize power, even whereas losing a few pounds.